Related Experiment Video
Updated: Oct 7, 2025

14:15
Multicolor 3D Printing of Complex Intracranial Tumors in Neurosurgery
Published on: January 11, 2020
7.3K
Three-Dimensional Printing Chitosan-Based Bolus Used for Radiotherapy.
Ying Lu1, Fan Wang2, Qinying Shi1
1Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Taiyuan 030032, Shanxi Province, China.
ACS Applied Bio Materials
|January 10, 2022
Summary
Researchers developed a new chitosan-based bioink for 3D printing custom radiotherapy boluses. This 3D printed material ensures better skin contact, improving radiation dose accuracy for superficial lesions.
Area of Science:
- Biomaterials Science
- Radiotherapy Physics
- Biomedical Engineering
Background:
- Commercial radiotherapy boluses struggle to conform to irregular skin surfaces, causing air gaps and inaccurate radiation dosing.
- Customized bolus fabrication is crucial for effective radiotherapy of superficial lesions on areas like the scalp, nose, and ear.
Purpose of the Study:
- To develop a photocurable chitosan-based bioink for digital light processing (DLP) 3D printing of patient-specific radiotherapy boluses.
- To investigate the properties and efficacy of the 3D printed bolus for improved radiotherapy applications.
Main Methods:
- Chitosan was methacrylated to create a photosensitive bioink (CHI-MA) using methacrylic anhydride.
- Photosensitive crosslinkers of varying molecular weights were incorporated to modulate hydrogel properties.
- Digital Light Processing (DLP) 3D printing was used to fabricate complex bolus structures.
Main Results:
- The CHI-MA bioink demonstrated tunable photocuring efficiency and mechanical properties.
- 3D printed CHI-MA hydrogels exhibited good biocompatibility, flexibility, and structural stability.
- A 3D printed nose bolus showed excellent fit on a model and a desirable radiotherapy effect.
Conclusions:
- DLP 3D printing of CHI-MA bioink offers a promising method for creating customized radiotherapy boluses.
- This approach addresses the limitations of commercial boluses by ensuring conformal contact and accurate dose delivery.
- The developed bioink holds potential for improving radiotherapy treatment of superficial lesions.

